Active — Not RecruitingPhase 3

NOVOCART 3D Treatment Following Microfracture Failure

United States, Canada30 participantsStarted 2018-11-30

Plain-language summary

This study is prospective single arm extension study of protocol AAG-G-H-1220. It is open only to participants of AAG-G-H-1220 randomized to the Microfracture treatment group.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * participated in study AAG-G-H-1220 * identified as a microfracture failure patient * voluntary consent to participate in the study Exclusion Criteria: * other cartilage repair procedures performed on target knee * other conditions that would interfere with healing or evaluating outcomes * lesions requiring implants larger than 9cm2 * non-compliance with requirements in study AAG-G-H-1220

What they're measuring

KOOS pain subdomain score

Timeframe: 24 months

Trial details

NCT IDNCT03219307

SponsorAesculap Biologics, LLC

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-01

View on ClinicalTrials.gov More Articular Cartilage Defect trials